E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/9/2023 in the Prospect News Convertibles Daily.

New Issue: TransMedics prices upsized $400 million five-year convertible notes at 1.5%, up 32.5%

By Abigail W. Adams

Portland, Me., May 9 – TransMedics Group Inc. priced an upsized $400 million of five-year convertible notes after the market close on Monday at par with a coupon of 1.5% and an initial conversion premium of 32.5%, according to a company news release.

Pricing came richer than talk for a coupon of 1.75% to 2.25% and at the rich end of talk for an initial conversion premium of 27.5% to 32.5%, according to a market source.

Morgan Stanley & Co. LLC (lead left) and J.P. Morgan Securities LLC were bookrunners for the Rule 144A offering, which carries an upsized greenshoe of $60 million.

The initial size of the offering was $300 million with a greenshoe of $45 million.

The notes are non-callable until June 8, 2026 and then subject to a 130% hurdle.

In connection with the offering, the company entered into capped call transactions with a cap price $141.88, which represents a 100% premium over the last reported sales price of stock.

Net proceeds are expected to be $387.2 million or will be $445.4 million if the greenshoe is exercised in full.

Approximately $45.3 million of net proceeds will be used to cover the cost of the call spread.

Remaining proceeds will be used to expand its logistics network through partnerships and acquisitions and for general corporate purposes.

TransMedics is an Andover, Mass.-based medical technology company.

Issuer:TransMedics Group Inc.
Amount:$400 million
Greenshoe:$60 million
Issue:Convertible senior notes
Maturity:June 1, 2028
Bookrunners:Morgan Stanley & Co. LLC (lead left) and J.P. Morgan Securities LLC
Coupon:1.5%
Price:Par
Yield:1.5%
Conversion premium:32.5%
Conversion price:$94.00
Conversion rate:10.6388
Call options:Non-callable until June 8, 2026 and then subject to a 130% hurdle
Pricing date:May 8
Settlement date:May 11
Distribution:Rule 144A
Talk:Coupon of 1.75% to 2.25% and initial conversion premium of 27.5% to 32.5%
Stock symbol:Nasdaq: TMDX
Stock price:$70.94 at market close May 8
Market capitalization:$2.31 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.